Encore Vision has completed patient enrollment for a phase 1/2 trial of topical EV06 ophthalmic solution for the treatment of presbyopia, according to a press release. The prospective, randomized, doublemasked, multicenter trial will examine the safety…
WAIKOLOA, Hawaii — Jetrea may not be as safe or cost-effective as vitrectomy for vitreomacular adhesion and macular hole closure, a speaker told colleagues here.“You’ve got to decide what’s best for your patients, recognizing that ocriplasmin will not achieve a success rate anywhere near that of a single operation, and to look at this issue of cost-adjustment,” William F. Mieler, MD, said at Retina 2016. “Perhaps ocriplasmin is just as expensive as a surgery. These issues are still ongoing. I still use ocriplasmin on occasion, but I think most of my patients opt for a vitrectomy approach, at least in my setting,”
Kids with uncorrected farsightedness lose ground on reading skills before they ever start first grade, a new study has found.
We are pleased to share with you that the APAO Leadership Development Program will be inducting its seventh class of 18 participants at the 31st APAO Congress to be held in Chinese Taipei from March 24 to 27. In the meantime, 14 participants in the gra…
NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation announced that the first patient has been dosed in a Phase 2/3 clinical study of Zimura® (avacincaptad pegol sodium).
WAIKOLOA, Hawaii — Current data indicate that anti-VEGF injections are an effective form of treatment for diabetic retinopathy, according to a speaker here. “Our current algorithm is based off some very old but very good data, the Diabetic Retinopathy Study, that was published in Ophthalmology in 1978, so we really have not deviated much from that since that time, and it shows that panretinal photocoagulation reduces the risk of severe vision loss by 50%,” Michael S. Ip, MD, said at Retina 2016. “But it really is an inherently destructive treatment.”